REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Hsu, Diane
Lee, Justin
Kotzen, Alison
Bensen, Rachel
Goyal, Alka
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2024年 / 30卷
关键词：
D O I：
10.1093/ibd/izae020.159
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
izae020.15
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
    Huettemann, Eva
    Muzalyova, Anna
    Groehl, Katharina
    Nagl, Sandra
    Fleischmann, Carola
    Ebigbo, Alanna
    Classen, Johanna
    Wanzl, Julia
    Prinz, Friederike
    Mayr, Patrick
    Schnoy, Elisabeth
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [32] Real-world outcomes of vedolizumab for inflammatory bowel disease post liver transplantation
    Peverelle, M. a
    Mills, C.
    Testro, A.
    de Cruz, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S356 - S357
  • [33] Efficacy and safety of vedolizumab in inflammatory bowel disease: Real-life experience
    Gonzalez Munoza, C.
    Mesonero, F.
    Bargallo, A.
    Clos, A.
    Arajol, C.
    Gordillo, J.
    Lopez-San Roman, A.
    Guardiola, J.
    Navarro-Llavat, M.
    Bertoletti, F.
    Fernandez, C.
    Domenech, E.
    Garcia-Planella, E.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S486 - S486
  • [34] REAL WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, L.
    Mosli, M.
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, R.
    Khalid, Mona
    Loftus, Edward V.
    INTERNIST, 2018, 59 : S55 - S56
  • [35] Real-World Study on Vedolizumab Serum Concentration, Efficacy, and Safety after the Transition from Intravenous to Subcutaneous Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Experience
    Fric, Vlasta Orsic
    Borzan, Vladimir
    Sahinovic, Ines
    Borzan, Andrej
    Kurbel, Sven
    PHARMACEUTICALS, 2023, 16 (02)
  • [36] Safety and Efficacy of Vedolizumab Use in Older Patients With Inflammatory Bowel Disease
    Shivashankar, Raina
    Aberra, Faten
    Ladd, Antonio Mendoza
    Lichtenstein, Gary R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S404 - S405
  • [37] Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study
    Holvoet, Tom
    Truyens, Marie
    De Galan, Cara
    Peeters, Harald
    Gismero, Francisco Mesonero
    Elorza, Ainara
    Torres, Paola
    Vandermeulen, Liv
    Jauregui-Amezaga, Aranzazu
    Ferreiro-Iglesias, Rocio
    Zabana, Yamile
    Reverter, Laia Peries
    Geldof, Jeroen
    Lobaton, Triana
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [38] Real-world effectiveness of ustekinumab and vedolizumab in TNF-exposed pediatric patients with ulcerative colitis
    Patel, Perseus V.
    Zhang, Amy
    Bhasuran, Balu
    Ravindranath, Vignesh G.
    Heyman, Melvin B.
    Verstraete, Sofia G.
    Butte, Atul J.
    Rosen, Michael J.
    Rudrapatna, Vivek A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (05): : 1126 - 1134
  • [39] PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB VERSUS VEDOLIZUMAB IN REAL-WORLD SETTINGS
    Chiorean, Michael V.
    Jiang, Jeanne
    Candela, Ninfa
    Chen, Grace
    Romdhani, Hela
    Latremouille-Viau, Dominick
    Shi, Sherry
    Bungay, Rebecca
    Fan, Tao
    GASTROENTEROLOGY, 2020, 158 (06) : S407 - S408
  • [40] Effectiveness and safety of vedolizumab in real-world studies in Chinese patients with inflammatory bowel disease: a systematic review and meta-analysis
    Gu, Y.
    Zhang, X.
    Gu, L.
    Zou, D.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1920 - I1922
12345